CellSight Technologies is a privately held biotechnology company based in San Francisco, California.
CellSight is enabling cell and gene therapies in living subjects through the use of imaging technologies. We offer custom imaging research services as well as prepackaged molecular imaging kits targeted at companies with imaging expertise as well as academic institutions. We have formed partnerships with large pharmaceutical companies to incorporate imaging studies during cell therapy & drug development.
The technology that forms the basis for the company was developed by Dr. Sanjiv Gambhir's group at the Molecular Imaging Program at Stanford (MIPS) and has been demonstrated in pre-clinical and clinical studies.
Sanjiv Sam Gambhir, MD, PhDChairman of Scientific Advisory Board
Virginia and D.K. Ludwig Professor in Cancer Research
Chairman, Department of Radiology at Stanford University School of Medicine
Professor (By courtesy), Bioengineering and Materials Science and Engineering at Stanford University
Director, Molecular Imaging Program at Stanford (MIPS)
Director, Canary Center at Stanford for Cancer Early Detection
World renown figure in molecular imaging with 25 years of biomedical imaging experience. Research focuses on methods to image gene expression in living subjects and imaging fundamental cellular events with optical and radiolabeled probes.
- MD and PhD, University of California Los Angeles
Michael Clarke, MDScientific Advisory Board
Associate Director, Stanford Institute for Stem Cell Biology and Regenerative Medicine
Dr. Clarke’s research is aimed at the identifications and characterization of cancer stem cells, and factors that control self-renewal in normal stem cells and their malignant counterparts.
- BA and MD, Indiana University
Aruna GambhirChief Executive Officer
Previously, Executive Director at Siebel Foundation and Marketing Director at Canary Foundation
Prior to that, 20 years experience in Sales, Marketing, Operations and Engineering in startups and multinational companies
- BS Biochemistry, University of California Berkeley
- MS Computer Science, Santa Clara University
- MBA, University of California Los Angeles
Sam QuezadaChief Operating Officer
Most recently IP and Corporate Relationsat the Molecular Imaging Program at Stanford
Nearly 30 years experience in Engineering, Marketing and Operations
- BSEE and MBA, Stanford University
Shahriar Yaghoubi, PhDChief Technology Officer
Managed several industry sponsored pre-clinical imaging projects
Director of Therapeutic Cell Imaging Trials and lead for FDA IND approval for [18F]FHBG
Over twelve years of experience in Molecular Imaging research at Stanford and UCLA
- BS Biomedical Engineering, University of Southern California
- PhD Molecular Medical Pharmacology, University of California Los Angeles